SCHEMBL20154088

SCHEMBL20154088

Cc1nc(Cl)c(Cl)c(N2CCN(C(=O)OC(C)(C)C)CC2C)n1

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SMARCA2 P51531 1/20 0.45
SMARCA4 P51532 1/20 0.45
PBRM1 Q86U86 1/20 0.45
GPR119 Q8TDV5 12/20 0.44
ABCB1 P08183 1/20 0.41
MAPT P10636 1/20 0.39
POLB P06746 1/20 0.38
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.36
THRB P10828 1/20 0.36
SETD7 Q8WTS6 1/20 0.36
CNR1 P21554 1/20 0.36
CNR2 P34972 1/20 0.36
CKS1B P61024 1/20 0.36
SKP1 P63208 1/20 0.36
SKP2 Q13309 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23426249 1.00 SMARCA2 (0.45) SMARCA2SMARCA4PBRM1GPR119ABCB1
SCHEMBL20154090 0.88 SMARCA2 (0.42) SMARCA2SMARCA4PBRM1GPR119ABCB1
SCHEMBL30234862 0.88 SMARCA2 (0.42) SMARCA2SMARCA4PBRM1GPR119ABCB1
SCHEMBL20154073 0.88 SMARCA2 (0.42) SMARCA2SMARCA4PBRM1GPR119ABCB1
SCHEMBL20154158 0.82 POLB (0.46) SMARCA2SMARCA4PBRM1GPR119MAPT
SCHEMBL23426258 0.81 GPR119 (0.42) SMARCA2SMARCA4PBRM1GPR119ABCB1
SCHEMBL30234844 0.80 GPR119 (0.41) SMARCA2SMARCA4PBRM1GPR119ABCB1
SCHEMBL20154071 0.80 GPR119 (0.41) SMARCA2SMARCA4PBRM1GPR119ABCB1
SCHEMBL25982105 0.79 GPR119 (0.42) SMARCA2SMARCA4PBRM1GPR119ABCB1
SCHEMBL4319554 0.79 GPR119 (0.50) SMARCA2SMARCA4PBRM1GPR119ABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018087527-A1 PYRIMIDINONE DERIVATIVES AS CDC7 INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2018-05-17 WO disclosed